Ovarian cancer patients survive longer with BRCA2 mutated in tumors, study finds
Tuesday, October 11, 2011 - 16:30
in Health & Medicine
Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers report.